Mydecine Innovations Group Stock Price Prediction
| MYCOF Stock | USD 0.01 0 25.00% |
Oversold Vs Overbought
45
Oversold | Overbought |
Using Mydecine Innovations hype-based prediction, you can estimate the value of Mydecine Innovations Group from the perspective of Mydecine Innovations response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mydecine Innovations to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Mydecine because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mydecine Innovations after-hype prediction price | USD 0.003167 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mydecine |
Mydecine Innovations After-Hype Price Prediction Density Analysis
As far as predicting the price of Mydecine Innovations at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mydecine Innovations or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Mydecine Innovations, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mydecine Innovations Estimiated After-Hype Price Volatility
In the context of predicting Mydecine Innovations' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mydecine Innovations' historical news coverage. Mydecine Innovations' after-hype downside and upside margins for the prediction period are 0.00 and 33.16, respectively. We have considered Mydecine Innovations' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mydecine Innovations is out of control at this time. Analysis and calculation of next after-hype price of Mydecine Innovations is based on 3 months time horizon.
Mydecine Innovations Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mydecine Innovations is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mydecine Innovations backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mydecine Innovations, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.80 | 33.16 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0 | 20.83 |
|
Mydecine Innovations Hype Timeline
Mydecine Innovations is now traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Mydecine is estimated to decline in value after the next headline, with the price expected to drop to 0.003167. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -20.83%, whereas the daily expected return is now at 3.8%. The volatility of related hype on Mydecine Innovations is about 0.0%, with the expected price after the next announcement by competition of 0.01. The company recorded a loss per share of 4.68. Mydecine Innovations last dividend was issued on the 1st of April 2019. The entity had 1:45 split on the 1st of April 2019. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out Mydecine Innovations Basic Forecasting Models to cross-verify your projections.Mydecine Innovations Related Hype Analysis
Having access to credible news sources related to Mydecine Innovations' direct competition is more important than ever and may enhance your ability to predict Mydecine Innovations' future price movements. Getting to know how Mydecine Innovations' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mydecine Innovations may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GEGI | Genesis Electronics Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NXMR | Nextmart | 0.00 | 0 per month | 17.92 | 0.1 | 50.00 | (55.56) | 419.44 | |
| EMGE | Emergent Health Corp | 0.00 | 0 per month | 0.00 | (0.04) | 18.18 | (16.67) | 40.00 | |
| WNFT | Goff Corp | 0.00 | 0 per month | 10.10 | 0.10 | 29.41 | (18.92) | 201.23 | |
| GCLT | GainClients | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mydecine Innovations Additional Predictive Modules
Most predictive techniques to examine Mydecine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mydecine using various technical indicators. When you analyze Mydecine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mydecine Innovations Predictive Indicators
The successful prediction of Mydecine Innovations stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mydecine Innovations Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mydecine Innovations based on analysis of Mydecine Innovations hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mydecine Innovations's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mydecine Innovations's related companies.
Story Coverage note for Mydecine Innovations
The number of cover stories for Mydecine Innovations depends on current market conditions and Mydecine Innovations' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mydecine Innovations is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mydecine Innovations' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Mydecine Innovations Short Properties
Mydecine Innovations' future price predictability will typically decrease when Mydecine Innovations' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mydecine Innovations Group often depends not only on the future outlook of the potential Mydecine Innovations' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mydecine Innovations' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.2 M |
Complementary Tools for Mydecine Pink Sheet analysis
When running Mydecine Innovations' price analysis, check to measure Mydecine Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mydecine Innovations is operating at the current time. Most of Mydecine Innovations' value examination focuses on studying past and present price action to predict the probability of Mydecine Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mydecine Innovations' price. Additionally, you may evaluate how the addition of Mydecine Innovations to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |